Intero Biosystems
2 known investors
Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Intero Biosystems do?
- Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
- Who founded Intero Biosystems?
- Intero Biosystems was founded by Charlie Childs, Madeline Eiken, Jason Spence.
- Who are Intero Biosystems's investors?
- Intero Biosystems's investors include Houston Angel Network, Michigan Rise.